Site Members can sign up for company wide alerts
Lawsuit Overview
April 25, 2012 (Shareholders Foundation) -- An investor in NASDAQ:RDEA shares filed a lawsuit against directors of Ardea Biosciences, Inc in effort to block the proposed takeover of Ardea Biosciences, Inc by AstraZeneca for $32 per share. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duties owed to Ardea Biosciences investors arising ou...
You must register (for free) or login to view the entire case.